Atorvastatin Patent
May 16, 2012 at 17:55 | Source: Moneycontrol.com
Aug 29, 2008 at 19:55 | Source: CNBC-TV18
May 29, 2008 at 08:29 | Source: Business Line
Oct 31, 2007 at 18:42
Sep 13, 2007 at 15:15
Photos »
/ 
Related News »
(RTTNews) - Ind-Swift Ltd. added another feather in its cap by launching generic formulations of Atorvastatin in the UK in collaboration with Wockhardt UK Ltd. on the first day of its patent expiry. Atorvastatin is the world's best selling drug with world ...
May 17, 2012 at 05:57 | Source: RTT News
The drug's patent expired last November ... That doesn't mean that sometime in the future we may launch atorvastatin," He forecast that the decision not to launch certain products such as Atorvastatin and Simvastatin will cost the firm about $150 million.
May 29, 2012 at 04:03 | Source: Globes - Israel Business Arena
Last November the best-selling drug of all time, Lipitor (atorvastatin), another cardiology mainstay, went off patent, though it wasn’t until earlier this month that multiple generics became available. The FDA said that it had approved 300 mg ...
May 17, 2012 at 19:12 | Source: Forbes
The copycat version was launched on the first day of patent expiry in the UK, they said in a statement late on Wednesday. Lipitor, chemically known as atorvastatin, is the world's top selling drug with market size of about $16 billion ...
May 17, 2012 at 03:34 | Source: Reuters
One example of a change in strategy is Teva’s decision to not have a full-fledged U.S. launch of atorvastatin, the generic name for Lipitor, Pfizer’s blockbuster cholesterol drug, which lost patent protection last year. With seven or eight ...
May 25, 2012 at 10:20 | Source: Philadelphia Daily News
Niaspan is a more expensive brand while the cholesterol treatment market is flooded with cheaper generic statins, particularly since Lipitor late last year lost patent protection and is available in its cheaper generic form, atorvastatin.
May 17, 2012 at 22:40 | Source: Forbes
R&D spending is actually on the decline. We can't talk about the health of Pfizer's income without discussing the patent expiration it has been suffering from lately. The most famous is obviously atorvastatin (Lipitor), which I wrote extensively about in 2011.
May 22, 2012 at 18:59 | Source: Seekingalpha.com
The copycat version was launched on the first day of patent expiry in the UK, they said in a statement late on Wednesday. Lipitor, chemically known as atorvastatin, is the world's top selling drug with market size of about $16 billion ...
May 17, 2012 at 04:31 | Source: Reuters India
The company is marketing its version of Lipitor, or atorvastatin, in strengths of 10 milligrams ... with annual sales of as much as $13 billion. U.S. patent protection on the drug ended on Nov. 30. Watson Pharmaceuticals Inc. makes the ...
May 28, 2012 at 20:11 | Source: Yahoo Finance